Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Czech Academy of Sciences, Czech Republic
Title: Mitochondrially targeted compounds and its clinical potential

Jan has expertise in organic chemistry and has been participating in numerous projects involving synthesis of fytoestrogens, juvenile hormons as well as the chemistry of calixarenes, carboranes and derivatization of nanodiamonds. For the last 10 years he has been mainly focusing on medicinal chemistry and especially on novel mitochondrially targeted substances with promising biological activity. He is one of the inventors of the substance MitoTam, which is undergoing Phase I clinical trial involving oncological patients. He works as a scientist in the Service technology laboratory (STL) at Institute of Biotechnology Czech Academy of Sciences. STL design and synthetize not only mitochondrially targeted substances but also offers a custom synthesis or academic collaborations. Jan is also involved in advanced technology transfer including design, documentation and management of preclinical and clinical trials.


Mitochondria have been recently recognized as an emerging target for new anti-cancer drugs. Itis one of the main organelles in the cells participating in many important biochemical processes, including oxidative phosphorylation, which is crucial for the cell as a part of ATP synthesis. Mitochondria are also responsible for apoptosis by triggering the complex cell death process. A frequent approach to mitochondrial targeting is tagging the biologically active agents with lipophilic cation such as the alkyl triphenylphosponium moiety. Delocalized hydrophobic cations readily accumulate across the mitochondrial membrane due to the highly negative potential on the matrix side of the membrane. Here we will present novel mitochondrially targeted compounds developed by our team. An example is mitochondrially targeted tamoxifen (MitoTam), an inhibitor of complex I of the respiratory chain, which has recently entered Phase I clinical trial. We will present the biological properties of MitoTam including its synthesis from milligram amounts scaled up to kilogram amounts. The strategy of preclinical evaluation and its design needed for approval by the regulator prior to launching the Phase I clinical trial will also be discussed. Apart from the anti-cancer properties, MitoTam and its derivatives also selectively kill senescent cells. Cellular senescence is stress response activated in damaged cells. Inability of immune system to eliminate these senescence cells leads to development of age-related diseases, tissue damage, inflammation and enhanced carcinogenesis. Therefore, we can talk here about the repurposing of MitoTam to another clinically relevant scenario. Another field of our interest are mitochondrially targeted compounds with the ability to affectiron metabolism. Exemplified by deferoxamine derivatives, these agents feature a migrastatic and tumour suppressive properties. Synthesis and biological results of such compounds will be presented.

Special Issues
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by

Allied Academies Global Conference Directory

Mail us at

Program Manager
General Queries (WhatsApp)
More details about

Terms and Conditions


The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.


No insurance, of any kind, is included along with the registration in any of the events of the organization.


Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.


Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party nonprofit organization and this conference is not associated with any commercial meeting company.

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

All the bank charges applicable during refund will be deducted from the account of participant.

Cancellation Policy

All cancellations or modifications of registration must be made in writing to

Postponement of event

If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

Transfer of registration

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to . Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on April 04, 2015.

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

  • Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

    Accommodation Cancellation Policy:

    Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

    Authorization Policy

    Copyright © 2020-2021 Allied Academies, All Rights Reserved.